Article
DMC-BH derivative DMC-GF inhibits the growth of glioma stem cells by targeting the TRIM33/SLC25A1/mitochondrial oxidative phosphorylation pathway
2024-11-14
Abstract excerpt
<title>Abstract</title> <p>Glioma stem cells (GSCs) present formidable resistance to conventional radiotherapy and chemotherapy, thereby largely contributing to the high recurrence rates associated with gliomas. There is an urgent unmet clinical need for efficacious targeted therapeutics. Previously, we identified DMC-BH, a derivative of curcumin, exhibiting potent anti-glioma activity both in vitro and in vivo....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2422e34d-627b-5ac9-89af-21b22fcad842
- DOI
- 10.21203/rs.3.rs-5306321/v1
